Selected discussion
Evaluation of serum pancreatic lipase activity in dogs with myxomatous mitral valve disease.
Clinical evidence update from Journal of veterinary internal medicine
Clinical Context Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated A study published in Journal of veterinary internal medicine in 2026 evaluated evaluation of serum pancreatic lipase activity in dogs with myxomatous mitral valve disease..
Key Findings Previous studies have evaluated the association between myxomatous mitral valve disease (MMVD) and pancreatic lipase activity, but medications remain unconsidered. Elevated serum pancreatic lipase activity is related to cardiac medication in dogs with MMVD. Eighty-two client-owned dogs without clinical signs of pancreatitis (MMVD, n = 67 [stage B1 = 24; stage B2 = 22; non-medicated stage C = 9; medicated stage C = 12]; controls, n = 15). Retrospective cross-…
Discussion thread
Community replies
Follow the line down to read the conversation in order.
No replies yet
No replies yet. Be the first professional to join this discussion.
Use the reply box above to start the conversation.


Join this discussion
Add your reply
Share a professional insight, ask a focused question, or add relevant clinical experience.
Member participation
Log in to join the discussion
Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.